Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca; Prof. Dr. Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania. .
Prof. Dr. Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.
J Gastrointestin Liver Dis. 2022 Dec 17;31(4):453-458. doi: 10.15403/jgld-4506.
Sedation of elderly patients with associated comorbidities, subjected to ERCP procedure, can produce serious complications including respiratory instability and hemodynamics caused by the administration of anesthetic substances. In this study we aimed to evaluate whether the administration of lidocaine in continuous infusion during ERCP procedure reduces the consumption of propofol and the rate of complications in these patients.
83 patients over 65-year old, ASA II-IV score, undergoing an ERCP procedure were randomized in two groups: lidocaine group (group L) who received 1.5 mg/kg lidocaine 1% and propofol 1mg/kg at induction and then 2 mg/kg lidocaine 1% in continuous infusion during the procedure and control group (group C) who received saline in the same amount as group L and propofol 1mg/kg. The consumption of propofol, intraprocedural complications, the time of awakening and recovery, the quality of postprocedural analgesia, the satisfaction of the endoscopist were registered.
Propofol consumption was statistically significantly lower in group L compared to group C [135.37 (±43.23) vs. 214.88 (±51.83), p=0.001]. The same result was obtained related to the awakening time [2.85 (±1.50) vs. 5.38 (±1.36), p=0.001] and recovery time [23.90 (±12.66) vs. 26.17 (±12.41), p<0.001], the episodes of intraprocedural desaturation (p=0.001), the involuntary intraprocedural movements (p=0.001), the endoscopist's satisfaction (p=0.006). No differences were found in terms of post-procedure pain scores (p=0.54).
Lidocaine can be administered to reduce the need for propofol, faster awakening and lower intraprocedural complications in elderly patients undergoing the ERCP procedure.
在接受 ERCP 手术的老年合并症患者中进行镇静可能会导致严重并发症,包括麻醉物质给药引起的呼吸不稳定和血流动力学不稳定。在这项研究中,我们旨在评估 ERCP 手术过程中持续输注利多卡因是否可以减少这些患者的丙泊酚用量和并发症发生率。
83 名年龄在 65 岁以上、ASA II-IV 评分的患者接受 ERCP 手术,随机分为两组:利多卡因组(L 组),在诱导时给予 1.5mg/kg 利多卡因 1%和 1mg/kg 丙泊酚,然后在手术过程中持续输注 2mg/kg 利多卡因 1%;对照组(C 组),给予等量生理盐水和 1mg/kg 丙泊酚。记录丙泊酚用量、术中并发症、苏醒和恢复时间、术后镇痛质量、内镜医生满意度。
L 组丙泊酚用量明显低于 C 组[135.37(±43.23)vs. 214.88(±51.83),p=0.001]。苏醒时间[2.85(±1.50)vs. 5.38(±1.36),p=0.001]和恢复时间[23.90(±12.66)vs. 26.17(±12.41),p<0.001]也有类似的结果,术中脱氧血症发作(p=0.001)、术中不自主运动(p=0.001)、内镜医生满意度(p=0.006)也有类似的结果。术后疼痛评分无差异(p=0.54)。
在接受 ERCP 手术的老年患者中,给予利多卡因可以减少丙泊酚的需要量,加快苏醒速度,降低术中并发症。